Targacept, Inc.

Patents = 91

Forward Citations = 744

where 'Filed Patents' based on already Granted Patents

where 'Inventors Filed' based on already Granted Patents

104 inventors (with patents filed for the assignee):

Targacept, Inc. is a biopharmaceutical company that discovers and develops innovative therapeutic solutions for diseases of the central nervous system. Their focus lies in developing drugs targeting a class of receptors called nicotinic receptors, which play important roles in various CNS disorders. Targacept aims to improve the lives of patients through the discovery and advancement of effective treatments. For more information about Targacept, Inc., please visit their website.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com